Lupin announced it has received final approval from the Food and Drug Administration (FDA) for Valsartan Tablets, the generic version of NovartisDiovan.

Diovan is an angiotensin II receptor blocker indicated for the treatment of hypertension and heart failure. Diovan selectively blocks the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland. Its action is therefore independent of the pathways for angiotensin II synthesis.

RELATED: Hypertension Evaluation

Valsartan Tablets are available in 40mg, 80mg, 160mg, and 320mg strengths.

For more information call (800) 399-2561 or visit